Skip to main content
. 2009 Jun 26;5(6):e1000535. doi: 10.1371/journal.pgen.1000535

Figure 3. Calorie restriction or inactivation of the TOR pathway extends the life span of type II survivors.

Figure 3

(A) Calorie restriction in est2Δ type II survivors. Mean life span of strains shown: BY4742-2% Glucose, 23.6±9.3 (n = 56); BY4742-0.05% Glucose, 30.5±9.2 (n = 53); est2Δ type II-2% Glucose, 12.6±8.0 (n = 60); est2Δ type II-0.05% Glucose, 16.7±7.2 (n = 60). (B) Life span analysis in est2Δ type II survivors with TOR1 deletion. Mean life span of strains shown: BY4742, 24.8±11.1 (n = 60); tor1Δ, 29.4±12.9 (n = 60); est2Δ type II, 14.6±8.6 (n = 59); tor1Δ est2Δ type II, 22.0±9.1 (n = 58).